Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia

CompletedOBSERVATIONAL
Enrollment

8,000

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Hypercholesterolemia
Trial Locations (59)

Unknown

Research Site, Hong Kong

Research Site, Semarang

Research Site, Jakarta

Research Site, Sidoarjo

Research Site, Surabaya

Research Site, Medan

Research Site, Bandung

Research Site, Bangsar

Research Site, Kepong

Research Site, Kuala Lumpur

Research Site, Puchong

Research Site, Setapak

Research Site, Ampang

Research Site, Batu Caves

Research Site, Hulu Selangor

Research Site, Kampung Baru Subang

Research Site, Klang

Research Site, Kuala Selangor

Research Site, Petaling Jaya

Research Site, Port Klang

Research Site, Sekinchan

Research Site, Seri Kembangan

Research Site, Shah Alam

Research Site, Subang Jaya

Research Site, Sungai Buloh

Research Site, Sunway City

Research Site, Lipa

Research Site, Baguio City

Research Site, Davao City

Research Site, Iloilo City

Research Site, Manila

Research Site, Cheonan

Research Site, Bucheon-si

Research Site, Bundang

Research Site, Guri-si

Research Site, Il-san

Research Site, Suwon

Research Site, Masan

Research Site, Busan

Research Site, Daegu

Research Site, Daejeon

Research Site, Gwangju

Research Site, Incheon

Research Site, Jeju City

Research Site, Seoul

Research Site, Ulsan

Research Site, Kaohsiung City

Research Site, Taichung

Research Site, Tainan City

Research Site, Taipei

Research Site, Taoyuan District

Research Site, Bangkoknoi

Research Site, Dusit

Research Site, Pathumwan

Research Site, Ratchathewi

Research Site, Klongluang

Research Site, Muang

Research Site, Hanoi

Research Site, Ho Chi Minh City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY